BRCA2 and breast cancer: The majority of families with smaller aggregations of breast cancer do not yet have demonstrable underlying genetic defects and the majority of carriers of pathogenic mutations in BRCA1 and BRCA2 do not have strong aggregation of breast cancer in their families [6].